Ivermectin and Pharmacological Ascorbate in Cancer: Mechanistic Insights, Translational Challenges, and the Rationale for Future Combination Studies
The need for more effective cancer treatments has led to growing interest in drug repurposing and therapeutic approaches targeting cancer metabolism. Ivermectin and high-dose vitamin C have both been investigated for their possible anticancer effects. Ivermectin is an established antiparasitic drug, while vitamin C is an essential nutrient. Studies in experimental cancer models suggest that these compounds can affect cell survival through changes in oxidative stress, mitochondrial activity, metabolism and cell-death pathways. High-dose intravenous vitamin C differs from ordinary supplementation because it can reach millimolar concentrations in the blood. At these levels, ascorbate can promote hydrogen peroxide formation outside cells, increasing oxidative stress in susceptible cancer cells. Vitamin C also supports the activity of certain enzymes that depend on iron and 2-oxoglutarate. These enzymes are involved in the control of gene activity, cell development, and the way cells respond to oxygen levels. Although ivermectin and pharmacological ascorbate act through different mechanisms, some of their effects involve similar biological processes. Both have been associated with increased reactive oxygen species (ROS) production, mitochondrial dysfunction, activation of programmed cell death and changes in signalling pathways involved in cancer progression. This narrative review examines the molecular mechanisms, preclinical evidence, pharmacological limitations, and clinical experience associated with each compound. No direct preclinical or clinical cancer studies evaluating ivermectin and pharmacological ascorbate together were identified in the literature reviewed.
Authors
- Maria Rachele Ceccarini (ORCID: https://orcid.org/0000-0002-5344-4890)
- Michela Codini (ORCID: https://orcid.org/0000-0002-1562-4495)
- Tommaso Beccari (ORCID: https://orcid.org/0000-0001-9637-6579)
- Eleonora Manuali (ORCID: https://orcid.org/0009-0004-0614-2349)
Institutions
- University of Perugia (IT)
- Saint Camillus International University of Health and Medical Sciences (IT)
Publication Details
- Journal
- International Journal of Molecular Sciences
- Published
- 2026-11-17
- DOI
- https://doi.org/10.3390/ijms272210298
- Primary Topic
- Vitamin C and Antioxidants Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00